ArticleJournal of assisted reproduction and genetics2026
Shortened vitrification and warming improve survival and accelerate meiotic resumption in human germinal vesicle oocytes compared with standard protocols.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDo shortened vitrification and warming (S-V/W) protocols achieve similar survival rates and meiotic resumption compared with standard protocols in human germinal vesicle (GV) oocytes?
methodsA prospective sibling study was conducted with 230 vitrified human GV-oocytes obtained from 43 patients. Oocytes were divided into three groups: standard vitrification and warming protocols (STD-V/W), S-V/W protocols, and fresh control. Survival rates were assessed at 2 and 24 h post-warming. GV breakdown (GVBD, GV to MI) and maturation rates were assessed at 2, 4, 6, 24, and 48 h post-warming. An analytical model was developed to estimate laboratory workload associated with oocyte vitrification and warming under routine clinical conditions.
resultsThe S-V/W group showed higher survival rates compared with the STD-V/W group at 2 h [STD-V/W: 76/95 (80.0%) vs S-V/W: 90/98 (91.83%), p-value = 0.02] and 24 h [STD-V/W: 74/95 (77.89%) vs S-V/W: 88/98 (89.79%), p-value = 0.03]. The S-V/W group showed faster meiotic resumption, with a significantly higher GVBD rate at 2, and 6 h (p-value = 0.001 and p-value = 0.003, respectively), as well as earlier (6 h, p-value = 0.005) and increased MII appearance at 24 h (p-value = 0.010). The shortened protocol achieved an adjusted workload reduction of ~ 60-75% for vitrification and ~ 75-85% for warming.
conclusionsThis study highlights the advantages of the S-V/W protocols in improving survival rate, laboratory workflow, and accelerating meiotic resumption and MII appearance. In conclusion, these findings are promising and primarily support the need for further investigations in human mature oocytes.
Indexed as
Identifiers
42543464What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.